Cargando…

The effect of food and liquid pH on the integrity of enteric-coated beads from cysteamine bitartrate delayed-release capsules

BACKGROUND: Cysteamine bitartrate delayed-release (DR) capsule (Procysbi(®)) is approved for treatment of nephropathic cystinosis in the USA, Canada, and the EU. The capsules contain cysteamine bitartrate beads that are enteric coated with acid-resistant Eudragit L 30 D-55, preventing drug release i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavloff, Nadine, Hauser, Terry A, Williams, Chris, Isbell, Sara Louis, Cadieux, Ben, Johnson, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132578/ https://www.ncbi.nlm.nih.gov/pubmed/30233142 http://dx.doi.org/10.2147/DDDT.S174928

Ejemplares similares

The effect of food and liquid pH on the integrity of enteric-coated beads from cysteamine bitartrate delayed-release capsules [Corrigendum]
Publicado: (2018)

Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients
por: Klank, Sabrina, et al.
Publicado: (2023)

Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to “A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis”)
por: Langman, Craig B.
Publicado: (2023)

A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis
por: Armas, Danielle, et al.
Publicado: (2018)

Quality of Life is Improved and Kidney Function Preserved in Patients with Nephropathic Cystinosis Treated for 2 Years with Delayed-Release Cysteamine Bitartrate
por: Langman, Craig B., et al.
Publicado: (2014)

A novel sustained‐release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers
por: Berends, Cécile L., et al.
Publicado: (2021)

Cysteamine bitartrate delayed‐release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open‐label study of treatment‐naïve patients <6 years of age with nephropathic cystinosis
por: Vaisbich, Maria Helena, et al.
Publicado: (2021)

In vitro release and in vivo growth-promoting effects of coated cysteamine in broilers
por: Liu, Youyou, et al.
Publicado: (2023)

Release property study on the novel divalproex sodium enteric-coated capsules
por: Yang, Shuoye, et al.
Publicado: (2016)

A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis
por: van Stein, Christina, et al.
Publicado: (2021)

Single- and multiple-dose pharmacokinetics of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) compared with immediate-release hydrocodone bitartrate/ibuprofen and immediate-release tramadol HCl/acetaminophen
por: Devarakonda, Krishna, et al.
Publicado: (2015)

Development and characteristics of novel sonosensitive liposomes for vincristine bitartrate
por: Lin, Wen, et al.
Publicado: (2019)

Effects of Coated Cysteamine on Oxidative Stress and Inflammation in Weaned Pigs
por: Wang, Shanshan, et al.
Publicado: (2021)

A developed composite hard-gelatin capsules: delayed-release enteric properties
por: Nezhad Mohseni, Mozhgan, et al.
Publicado: (2022)

Biosynthesis and pharmacokinetics of Panax notoginseng enteric-coated soft capsules
por: Zheng, Ying, et al.
Publicado: (2023)

Hydration of a 2D Supramolecular Assembly: Bitartrate on Cu(110)
por: Lin, Chenfang, et al.
Publicado: (2020)

Nicotine Bitartrate Reduces Falls and Freezing of Gait in Parkinson Disease: A Reanalysis
por: Lieberman, Abraham, et al.
Publicado: (2019)

Influence of supplemented coated-cysteamine on morphology, apoptosis and oxidative stress status of gastrointestinal tract
por: Liu, Hongnan, et al.
Publicado: (2019)

Rabeprazole sodium delayed-release multiparticulates: Effect of enteric coating layers on product performance
por: Tirpude, Rakesh N., et al.
Publicado: (2011)

Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Zhang, Rong, et al.
Publicado: (2017)

Effects of coated cysteamine hydrochloride on muscle fiber characteristics and amino acid composition of finishing pigs
por: Bai, Miaomiao, et al.
Publicado: (2019)

Intracavernosal metaraminol bitartrate for treatment of priapism resulting from circumcision: a case report
por: Tang, Min, et al.
Publicado: (2016)

No Acute Effects of Choline Bitartrate Food Supplements on Memory in Healthy, Young, Human Adults
por: Lippelt, D. P., et al.
Publicado: (2016)

In Vitro Evaluation of Enteric-Coated HPMC Capsules—Effect of Formulation Factors on Product Performance
por: Fu, Maoqi, et al.
Publicado: (2020)

Ionic liquid-assisted cellulose coating of chitosan hydrogel beads and their application as drug carriers
por: Song, Myung-Hee, et al.
Publicado: (2020)

Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson’s disease
por: Hauser, Robert A., et al.
Publicado: (2022)

Cysteamine-coated gold nanoparticles for bimodal colorimetric detection with inverse sensitivity: a proof-of-concept with lysozyme
por: Wai, Jing Luen, et al.
Publicado: (2020)

Assessment of Alcohol-Induced Dose Dumping with a Hydrocodone Bitartrate Extended-Release Tablet Formulated with CIMA(®) Abuse Deterrence Technology
por: Darwish, Mona, et al.
Publicado: (2015)

Development and Comparison of Various Coated Hard Capsules Suitable for Enteric Administration to Small Patient Cohorts
por: Fülöpová, Nicole, et al.
Publicado: (2022)

Simultaneous Determination of Cysteamine and Cystamine in Cosmetics by Ion-Pairing Reversed-Phase High-Performance Liquid Chromatography
por: Kim, Yejin, et al.
Publicado: (2019)

Drug Physicochemical Properties and Capsule Fill Determine Extent of Premature Gastric Release from Enteric Capsules
por: Moghrabi, Fouad S., et al.
Publicado: (2022)

A monoclinic polymorph of cysteamine hydrochloride
por: Ahmad, Saeed, et al.
Publicado: (2009)

Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo
por: Jeitner, Thomas M., et al.
Publicado: (2018)

A Review on the Antimutagenic and Anticancer Effects of Cysteamine
por: Lee, Chun-Man
Publicado: (2023)

Cystinosis: Therapy adherence and metabolic monitoring in patients treated with immediate-release cysteamine
por: Linden, Simone, et al.
Publicado: (2020)

Comparison of single-dose and multiple-dose pharmacokinetics between two formulations of hydrocodone bitartrate/acetaminophen: immediate-release versus biphasic immediate-release/extended release
por: Devarakonda, Krishna, et al.
Publicado: (2015)

Superamphiphobic coatings based on liquid-core microcapsules with engineered capsule walls and functionality
por: Nordenström, Malin, et al.
Publicado: (2018)

Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs
por: Cui, Cheng, et al.
Publicado: (2020)

Efficacy of Bifidobacterium Triple Viable Enteric-Coated Capsules Combined with Enteral Nutrition on Patients with Chronic Critical Illness and Influence on Immune and Coagulation Function
por: Wang, Wei, et al.
Publicado: (2021)

A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain
por: Nalamachu, Srinivas, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_von1hne93eko3ovhrthm5qk8in